1. Home
  2. AEYE vs TTRX Comparison

AEYE vs TTRX Comparison

Compare AEYE & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioEye Inc.

AEYE

AudioEye Inc.

HOLD

Current Price

$7.24

Market Cap

91.0M

Sector

Technology

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$5.14

Market Cap

107.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AEYE
TTRX
Founded
2005
2015
Country
United States
United States
Employees
116
2
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.0M
107.2M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
AEYE
TTRX
Price
$7.24
$5.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$14.63
$8.00
AVG Volume (30 Days)
122.9K
27.9K
Earning Date
05-12-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
30.56
N/A
EPS
N/A
N/A
Revenue
$40,311,000.00
N/A
Revenue This Year
$11.12
N/A
Revenue Next Year
$11.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.52
N/A
52 Week Low
$5.31
$2.57
52 Week High
$16.39
$5.98

Technical Indicators

Market Signals
Indicator
AEYE
TTRX
Relative Strength Index (RSI) 50.31 77.91
Support Level $6.50 $4.11
Resistance Level $7.42 $5.55
Average True Range (ATR) 0.52 0.33
MACD -0.07 0.12
Stochastic Oscillator 56.36 94.03

Price Performance

Historical Comparison
AEYE
TTRX

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: